Mobile Cardiac Telemetry Devices Market: Current Scenario and Forecast (2019-2025): Emphasis on Technology (Lead-Based, Patch Based), End-Users (Hospitals, Ambulatory Surgical Centres, Home Setting) and Region/Country
November 2019
231
About the Report
About the Report
Mobile cardiac telemetry devices derived revenue of USD 563.7 million in 2018 and are expected to fetch USD 1,264 million by 2025 displaying tremendous CAGR of 12.34% over the forecast period (2019-2025). The global Mobile Cardiac Telemetry Devices market is segmented based on technology (lead-based and patch-based devices) and end-user (hospitals, ambulatory surgical centers and home settings). Under the technology segment, in 2018, the lead-based devices dominated the global mobile cardiac telemetry devices market with the maximum share in terms of revenue. Based on estimation, the segment occupied 60.2% share. However, the patch-based devices are anticipated to grow by the highest CAGR of 13.25%. In recent years the prevalence of chronic diseases has increased due to the rise in life expectancy and changes in lifestyle, and thus people suffering from these pathologies often need continuous monitoring of their vital signs. The mobile health field can provide new access opportunities for treatment and medical services, constituting a valuable support instrument for both patients and doctors. Mobile cardiac telemetry (MCT) is a relatively new technology, first approved in 2002 by the US Food and Drug Administration (FDA), which provides continuous real-time outpatient electrocardiographic monitoring for extended periods of time. MCT allows detection of both symptomatic and asymptomatic arrhythmias and has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope. It also allows accurate monitoring of a patient's rhythm during outpatient drug titration, as well as detection of both symptomatic and asymptomatic atrial fibrillation after cardiac ablation. The lead based MCT devices market at global scale was evaluated at USD 339.2 million in 2018 and is projected to witness astonishing CAGR of 11.71% during the forecast period. In addition, patch-based devices held 39.8% market share in the respective market generating revenue of USD 224.5 million in 2018.
Mobile Cardiac Telemetry (MCT) is becoming common as the device is far less labor-intensive for the patient as compared to the traditional Event Monitor. Cardiac Event Monitor is a device used for detecting ONLY symptoms felt by the patient. The MCT monitor has the capability of transmitting both symptoms felt by the patient as well as abnormalities that are not felt by the patient. Furthermore, MCT monitoring is useful as the communication is constant if there are messages needed to be transmitted to the patient, the process is simple and reliable because it uses standard cell phone technology. Mobile Cardiac Telemetry monitoring is the wave of the future, owing to its multiple advantages compared to other long-term monitoring options. MCT monitoring technology can be considered a superior method for detecting ECG abnormalities as it captures cardiac abnormalities in real-time. The expedited nature of MCT can potentially improve diagnostic care and lower healthcare costs over the long run. The automatic monitoring outside the hospital provides clear clinical benefits for the patients, physicians and healthcare providers. Potential medically relevant problems can be recognized and addressed proactively, avoiding unnecessary hospitalization costs.
Secondly, the robust incorporation of (cardiac) telemonitoring into a given clinic's work routine will likely require a commitment to redirect certain internal resources and work processes in order to reap the full benefits of a telemetric patient monitoring. Unlike many medical innovations, the true benefits of cardiac telemonitoring will be spread among those involved in the patient care cycle. Finally, a growing number of hospitals and pacemaker clinics have already recognized the inherent value of adopting this new technology to improve work efficiency, deliver more timely urgent medical responses when cardiac events occur. They also use this technology for establishing a productive professional interface with a given patient's non-specialist physicians and caregivers.
Hospitals are the major end-users of mobile telemetry device technology; the segment generated a revenue of USD 350.5 million in 2018. The hospital's end-user segment is expected to grow at a CAGR of 11.67% during the forecast period to reach a market size of USD 753.8 million by 2025. However, home setting is expected to witness highest CAGR of 14.92% during the forecast period (2019-2025).
Also, for better understanding of the overall adoption rate of mobile cardiac telemetry devices in different developed and developing markets, detailed analysis has been conducted for different regions/countries including North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World (Middle East and Latin America). Based on the estimation, Europe dominated the Mobile Cardiac Telemetry devices market, accounting for a revenue share of 31.9% in 2018. The rising incidence of cardiovascular diseases in Europe is influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market.
Key Facts on Cardiovascular diseases (CVDs), Global
CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cause.
An estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke.
Over three-quarters of CVD deaths take place in low- and middle-income countries.
Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2015, 82% are in low- and middle-income countries, and 37% are caused by CVDs.
Most cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies.
People with cardiovascular disease or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidemia or already established disease) need early detection and management using counseling and medicines, as appropriate
Numerous companies have marked their presence in the mobile cardiac telemetry devices market with a continued focus on product expansions, investments, business expansion, product launches and collaborations. They continue to offer wide range of smart devices that cater to farm needs and further result in enhanced crop productivity and optimum utilization of resources. With an objective to stimulate the overall adoption of mobile cardiac telemetry devices across the developing and developed nations specifically in the Asia Pacific, Europe region, these players have adopted various strategies to enhance the penetration of modern mobile cardiac telemetry devices. Some of the major players operating in the global mobile cardiac telemetry devices market include Asahi Kasei Corp., BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp and Preventice among others.
Global Mobile Cardiac Telemetry Devices market generated revenue of USD 563.7 million in 2018. The devices market is expected to grow at a CAGR of 12.34% during the forecast period to reach a market valuation of USD 1,264 million by 2025. Europe dominated the global mobile cardiac telemetry devices market, accounting for a revenue share of 31.9% in 2018.
Products
Companies
Asahi Kasei Corporation, BioTelemetry Inc, Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp, Preventice Solutions
Table of Contents
Table of Contents
1. MARKET INTRODUCTION
1.1 Market Definition 17
1.2 Objective of the Study 17
1.3 Limitation 17
1.4 Stakeholders 18
1.5 Currency used in the Report 18
1.6 Scope of the Global Mobile Cardiac Telemetry Devices Market Study 18
2. RESEARCH METHODOLOGY OR ASSUMPTION 19
2.1 Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study 19
2.1.1 Main objective of the Global Mobile Cardiac Telemetry Devices Market Study 20
3. INDUSTRY PERFORMANCE 21
4. EXECUTIVE SUMMARY 22
4.1 Key Facts on Cardiovascular diseases (CVDs), Global 23
5. MARKET OVERVIEW 25
5.1 Market Introduction 25
5.2 Market Trend & Drivers 29
5.2.1 Increasing prevalence of Cardiovascular Diseases 29
5.2.1.1 Market trends reshaping the CVD market 31
5.2.1.1.1 Increasing demand for value 31
5.2.1.1.2 The rising uptake of Innovative Treatment Technologies 32
5.2.1.1.3 Growing Digital Solutions Adoption 33
5.2.1.1.4 Changing MedTech competitive landscape 33
5.2.1.1.5 Evolving provider and care delivery shifts 34
5.2.2 Rising Geriatric Population 34
5.2.3 Next-Generation Devices for Miniaturization, Faster Processing and Connectivity 36
5.2.4 Increasing Medical Tourism in Emerging Nations 36
5.3 Market Challenges 38
5.3.1 Clinical Effectiveness 38
5.3.2 Need for validation, cost-effectiveness 40
5.3.3 Data Security 41
5.4 Market Trends 43
5.4.1 Interoperability and Wireless Technology to Enhance Real-Time, Remote Monitoring 43
5.4.2 Transition of Care Delivery from Hospital to Home 45
6. REIMBURSEMENT POLICY 46
6.1 General Overview 46
6.1.1 Holter Monitoring reimbursement 46
6.1.2 Mobile Cardiac Telemetry Reimbursement 46
6.1.3 Cardiac Event Monitoring Reimbursement 47
6.2 Medicare National Coverage 47
6.3 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/ telemetry 47
6.3.1 Reimbursement 53
6.3.2 Reimbursement in Europe 55
7. LEGAL & REGULATORY FRAMEWORK 59
7.1 General Overview 59
7.2 Criteria/Guidelines 60
7.3 Criteria/Guidelines 60
7.4 Limitations 61
7.5 Administrative Guidelines 61
7.6 Observational Study 63
7.7 Practice Guidelines and Position Statements 63
7.8 Telemetry Devices to Monitor Cardiac Patients: Safety and Guidelines in Canada 64
7.9 The legal framework in regulating remote (cardiac) monitoring in France 64
7.10 The legal framework in regulating remote (cardiac) monitoring in Italy 64
8. DEMAND AND SUPPLY SIDE ANALYSIS 66
8.1 Demand Side Analysis 66
8.2 Supply Side Analysis 68
8.2.1 Top Product Launches under Mobile Cardiac Telemetry Devices 70
8.2.2 Top Partnerships under Mobile Cardiac Telemetry Devices 72
8.2.3 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 73
8.2.4 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 75
9. VALUE CHAIN ANALYSIS 77
9.1 Value Chain Analysis 77
10. MARKET INSIGHTS BY TECHNOLOGY 78
10.1 General Overview 78
10.1.1 Lead-Based MCT Device 80
10.1.1.1 Case Study 1- Superiority of MCT Devices 83
10.1.2 Patch Based MCT Device 83
10.1.2.1 Case study 2- Superiority of MCT Devices 85
11. MOBILE CARDIAC TELEMETRY DEVICE MARKET INSIGHTS, BY END-USERS 86
11.1 General Overview 86
11.1.1 Hospitals 90
11.1.1.1 Case Study 3- Superiority of MCT Devices 92
11.1.2 Ambulatory Surgical Centres 92
11.1.2.1 Case study 4- Superiority of MCT Devices 94
11.1.3 Home Setting 94
11.1.3.1 Case Study 5-Cost-Effectiveness of Mobile Cardiac Telemetry 97
12. MARKET INSIGHTS BY REGION 98
12.1 General Overview 98
12.2 North America Mobile Cardiac Telemetry Devices Market (2019-2025) 99
12.2.1 North America MCT Devices Market by Technology 100
12.2.2 North America Mobile Cardiac Telemetry Devices Market by End-User 101
12.2.3 North America Mobile Cardiac Telemetry Devices Market by Country 101
12.2.3.1 United States Mobile Cardiac Telemetry Devices Market (2019-2025) 102
12.2.3.1.1 Facts on Heart Disease in the US 104
12.2.3.1.2 Facts on Coronary Heart Disease (CHD) in the US 104
12.2.3.1.3 Facts on Stoke in the US 105
12.2.3.1.4 US Mobile Cardiac Telemetry Devices Market by Technology 106
12.2.3.1.5 US Mobile Cardiac Telemetry Devices Market by End-User 106
12.2.3.2 Canada Mobile Cardiac Telemetry Devices Market (2018-2025) 107
12.2.3.2.1 Facts on heart disease in Canada 110
12.2.3.2.2 Canada Mobile Cardiac Telemetry Devices Market by Technology 110
12.2.3.2.3 Canada Mobile Cardiac Telemetry Devices Market by End-User 111
12.2.3.3 Rest of North America Mobile Cardiac Telemetry Devices Market (2018-2025) 111
12.2.3.3.1 Rest of NA Mobile Cardiac Telemetry Devices Market by Technology 112
12.2.3.3.2 Rest of NA Mobile Cardiac Telemetry Devices Market by End-User 112
12.3 Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 113
12.3.1 Facts on Cardiovascular Disease in Europe 114
12.3.2 Europe Mobile Cardiac Telemetry Devices Market by Technology 115
12.3.3 Europe Mobile Cardiac Telemetry Devices Market by End-User 115
12.3.4 Europe Mobile Cardiac Telemetry Devices Market by Country 116
12.3.4.1 France Mobile Cardiac Telemetry Devices Market (2019-2025) 116
12.3.4.1.1 France Mobile Cardiac Telemetry Devices Market by Technology 117
12.3.4.1.2 France Mobile Cardiac Telemetry Devices Market by End-User 118
12.3.4.2 Germany Mobile Cardiac Telemetry Devices Market (2018-2025) 118
12.3.4.2.1 Germany Mobile Cardiac Telemetry Devices Market by Technology 121
12.3.4.2.2 Germany Mobile Cardiac Telemetry Devices Market by End-User 121
12.3.4.3 Sweden Mobile Cardiac Telemetry Devices Market (2018-2025) 122
12.3.4.3.1 Sweden Mobile Cardiac Telemetry Devices Market by Technology 124
12.3.4.3.2 Sweden Mobile Cardiac Telemetry Devices Market by End-User 125
12.3.4.4 Netherlands Mobile Cardiac Telemetry Devices Market (2018-2025) 125
12.3.4.4.1 Netherlands Mobile Cardiac Telemetry Devices Market by Technology 127
12.3.4.4.2 Case Study-Cost effectiveness of home telemonitoring (HTM) and nurse telephone support (NTS) 127
12.3.4.4.3 Netherlands Mobile Cardiac Telemetry Devices Market by End-User 128
12.3.4.5 Italy Mobile Cardiac Telemetry Devices Market (2018-2025) 128
12.3.4.5.1 Italy Mobile Cardiac Telemetry Devices Market by Technology 133
12.3.4.5.2 Italy Mobile Cardiac Telemetry Devices Market by End-User 133
12.3.4.6 United Kingdom Mobile Cardiac Telemetry Devices Market (2018-2025) 134
12.3.4.6.1 United Kingdom Mobile Cardiac Telemetry Devices Market by Technology 135
12.3.4.6.2 United Kingdom Mobile Cardiac Telemetry Devices Market by End-User 135
12.3.4.7 Rest of Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 136
12.3.4.7.1 Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology 136
12.3.4.7.2 Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User 137
12.4 Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 137
12.4.1 Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology 138
12.4.2 Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User 139
12.4.3 Asia Pacific Mobile Cardiac Telemetry Devices Market by Country 139
12.4.3.1 Japan Mobile Cardiac Telemetry Devices Market (2018-2025) 140
12.4.3.1.1 Japan Mobile Cardiac Telemetry Devices Market by Technology 141
12.4.3.1.2 Japan Mobile Cardiac Telemetry Devices Market by End-User 142
12.4.3.2 China Mobile Cardiac Telemetry Devices Market (2018-2025) 142
12.4.3.2.1 China Mobile Cardiac Telemetry Devices Market by Technology 144
12.4.3.2.2 China Mobile Cardiac Telemetry Devices Market by End-User 144
12.4.3.3 India Mobile Cardiac Telemetry Devices Market (2018-2025) 145
12.4.3.3.1 India Mobile Cardiac Telemetry Devices Market by Technology 146
12.4.3.3.2 India Mobile Cardiac Telemetry Devices Market by End-User 147
12.4.3.4 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 147
12.4.3.4.1 Rest of APAC Mobile Cardiac Telemetry Devices Market by Technology 148
12.4.3.4.2 Rest of APAC Mobile Cardiac Telemetry Devices Market by End-User 148
12.5 Rest of World Mobile Cardiac Telemetry Devices Market (2018-2025) 149
12.5.1 Rest of World Mobile Cardiac Telemetry Devices Market by Technology 150
12.5.2 Rest of World Mobile Cardiac Telemetry Devices Market by End-User 150
12.5.3 Rest of World Mobile Cardiac Telemetry Devices Market by Country 151
12.5.3.1 South Africa Mobile Cardiac Telemetry Devices Market (2018-2025) 151
12.5.3.1.1 South Africa Mobile Cardiac Telemetry Devices Market by Technology 153
12.5.3.1.2 South Africa Mobile Cardiac Telemetry Devices Market by End-User 153
12.5.3.2 Brazil Mobile Cardiac Telemetry Devices Market (2018-2025) 154
12.5.3.2.1 Brazil Mobile Cardiac Telemetry Devices Market by Technology 155
12.5.3.2.2 Brazil Mobile Cardiac Telemetry Devices Market by End-User 156
12.5.3.3 Other Countries Mobile Cardiac Telemetry Devices Market (2018-2025) 156
12.5.3.3.1 Other RoW Mobile Cardiac Telemetry Devices Market by Technology 156
12.5.3.3.2 Other RoW Mobile Cardiac Telemetry Devices Market by End User 157
13. COMPETITIVE SCENARIO 158
13.1 Porter s Five forces analysis 158
13.1.1 Bargaining power of the Supplier 158
13.1.2 Bargaining power of Buyer 159
13.1.3 Industry Rivalry 159
13.1.4 Availability of Substitute 159
13.1.5 Threat of New Entrants 159
13.2 Market Share Analysis, by Company 2018 160
13.2.1 Some Major agreements of BioTelemetry 160
13.2.2 Market Share of Key Players in Mobile Cardiac Telemetry Devices, 2018 161
14. TOP COMPANY PROFILES 163
14.1 Asahi Kasei Corporation 163
14.1.1 Key Facts 163
14.1.2 Business Description 163
14.1.3 Key Product/Services Offerings 164
14.1.4 Growth Strategy 165
14.1.5 SWOT Analysis 167
14.1.6 Key Financials 168
14.1.6.1 Revenue Split 169
14.1.7 Recent Developments 169
14.1.7.1 Product Launches 169
14.1.7.2 Partnerships 170
14.1.7.3 Mergers and Acquisitions 170
14.2 BioTelemetry Inc. 171
14.2.1 Key Facts 171
14.2.2 Business Description 171
14.2.3 Key Product/Services Offerings 172
14.2.4 Growth Strategy 172
14.2.5 SWOT Analysis 173
14.2.6 Key Financials 174
14.2.6.1 Revenue Split 175
14.2.7 Recent Developments 175
14.2.7.1 Partnerships (Strategic Alliance) 175
14.2.7.2 Mergers and Acquisitions 175
14.3 Biotricity 177
14.3.1 Key Facts 177
14.3.2 Business Description 177
14.3.3 Key Product/Services Offerings 178
14.3.4 Growth Strategy 180
14.3.5 SWOT Analysis 181
14.3.6 Key Financials 181
14.3.7 Recent Developments 182
14.3.7.1 Biotricity Product Launch 182
14.3.7.2 Biotricity Business Expansion and Investment 183
14.4 Comarch 184
14.4.1 Key Facts 184
14.4.2 Business Description 184
14.4.3 Key Product/Services Offerings 185
14.4.4 Growth Strategy 186
14.4.5 SWOT Analysis 187
14.4.6 Key Financials 188
14.4.6.1 Revenue Split 189
14.4.7 Recent Developments 189
14.4.7.1 Partnership 189
14.4.7.2 Business Expansion & Investments 190
14.5 Hill-Rom Holdings Inc 191
14.5.1 Key Facts 191
14.5.2 Business Description 191
14.5.3 Key Product/Services Offerings 192
14.5.4 Growth Strategy 193
14.5.5 SWOT Analysis 195
14.5.6 Key Financials 196
14.5.6.1 Revenue Split 197
14.5.7 Recent Developments 197
14.5.7.1 Product Launches 197
14.5.7.2 Partnership 198
14.5.7.3 Expansions and Investments 198
14.5.7.4 Mergers and Acquisitions 198
14.5.7.5 Product Launches 199
14.6 Infobionic 200
14.6.1 Key Facts 200
14.6.2 Business Description 200
14.6.3 Key Product/Services Offerings 200
14.6.4 Growth Strategy 201
14.6.5 SWOT Analysis 202
14.6.6 Recent Developments 203
14.6.6.1 Product Launch 203
14.6.6.2 Business Expansion and Investment 203
14.7 Koninklijke Philips N.V. 204
14.7.1 Key Facts 204
14.7.2 Business Description 204
14.7.3 Key Product/Services Offerings 205
14.7.4 SWOT Analysis 207
14.7.5 Key Financials 208
14.7.5.1 Revenue Split, by Region and Segment 209
14.7.6 Recent Developments 209
14.7.6.1 Product Launches 209
14.7.6.2 Partnership 210
14.7.6.3 Merger and Acquisition 210
14.8 Medicalgorithmics 211
14.8.1 Key Facts 211
14.8.2 Business Description 211
14.8.3 Key Product/Services Offerings 212
14.8.4 SWOT Analysis 214
14.8.5 Key Financials 215
14.8.5.1 Revenue Split 216
14.8.6 Recent Developments 216
14.8.6.1 Product Launch 216
14.8.6.2 Partnerships 217
14.8.6.3 Business Expansions and Investments 217
14.8.6.4 Merger & Acquisitions 217
14.9 Medicomp 218
14.9.1 Key Facts 218
14.9.2 Business Description 218
14.9.3 Key Product/Services Offerings 218
14.9.4 SWOT Analysis 220
14.9.5 Recent Developments 220
14.9.5.1 Product Launches 220
14.10 Preventice Solutions 221
14.10.1.1 Key Facts 221
14.10.2 Business Description 221
14.10.3 Key Product/Services Offerings 222
14.10.4 SWOT Analysis 224
14.10.5 Recent Developments 225
14.10.5.1 Product Launches 225
List of Figure
FIG. 1 Scope of the Global Mobile Cardiac Telemetry Devices Market Study 19
FIG. 2 Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study 20
FIG. 3 Global Mobile Cardiac Telemetry Devices Market Size, 2018-2025 (USD Million) 25
FIG. 4 A WBAN architecture for ECG monitoring 28
FIG. 5 Cardiovascular diseases (CVDs) at a Glance, 2017 30
FIG. 6 Total number of deaths due to cardiovascular diseases in the world 2017: 17.3m 31
FIG. 7 Direct Cost of CVD is expected to double from 2011 to 2025 31
FIG. 8 Five market trends impacting the cardiovascular landscape 32
FIG. 9 Value-based Care Payment Models 33
FIG. 10 Global population by broad age group, in 2017, 2030 and 2050 36
FIG. 11 Average Range of Savings in Medical Tourism Using US cost as a benchmark 38
FIG. 12 Potential Consequences of Telemetry Monitoring 40
FIG. 13 Adverse Hospital Outcomes 41
FIG. 14 Potential Benefits of Vital Signs Surveillance 42
FIG. 15 Typical Cloud Computing Structure for Healthcare Systems 44
FIG. 16 Telemonitoring System via Cellular Access 45
FIG. 17 Types of AECG monitors currently available in clinical practice-First-generation external ambulatory ECG monitoring 50
FIG. 18 Second generation external ambulatory ECG monitoring available in clinical practice 51
FIG. 19 Major Risk Factors and Comorbidity for CVD 67
FIG. 20 Major CVD Coexisting Medical Conditions* 2016 68
FIG. 21 Supply Chain of Medical monitoring devices 70
FIG. 22 Value Chain of Medical monitoring devices 78
FIG. 23 Pictorial representation of Lead-based, and Patch-based Mobile Cardia Telemetry Device 79
FIG. 24 Global Mobile Cardiac Telemetry Devices Market Share, by Technology, 2018 & 2025 (%) 80
FIG. 25 Global Mobile Cardiac Telemetry Devices Market Size, by Technology, 2018-25 (USD Mn) 80
FIG. 26 Telemetry functions with 5 lead placements 82
FIG. 27 Global Lead-Based Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 83
FIG. 28 Process of Patch based Mobile Cardiac Telemetry 85
FIG. 29 Global Patch Based Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 86
FIG. 30 Dollar Market Share of Cardiac Monitoring Modalities 2018 (%) 89
FIG. 31 Global Mobile Cardiac Telemetry Devices Market Share, by End-User, 2018 & 2025 (%) 90
FIG. 32 Global Mobile Cardiac Telemetry Devices Market Size, by End-Users, 2018-25 (USD Mn) 90
FIG. 33 Mobile Cardiac Telemetry System in hospitals 91
FIG. 34 Global Hospital Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 93
FIG. 35 Global Ambulatory Surgical Centres Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 94
FIG. 36 Mobile Cardiac Telemetry System signal transmission in-home setting 95
FIG. 37 The process of use of mobile cardiac telemetry device in home settings 96
FIG. 38 Reasons for Mobile Cardiac Telemetry System implementation in-home setting 96
FIG. 39 Global Home Settings Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 97
FIG. 40 Global Mobile Cardiac Telemetry Devices Market by Region, 2019 & 2025 (%) 99
FIG. 41 Global Mobile Cardiac Telemetry Devices Market by Region, 2019-25 (USD Million) 99
FIG. 42 North America MCT Devices Market by Technology, 2018-2025 (USD million) 101
FIG. 43 North America Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 102
FIG. 44 North America Mobile Cardiac Telemetry Devices Market by Country, 2018- 2025 (USD Million) 102
FIG. 45 US Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 107
FIG. 46 US Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 107
FIG. 47 Diagnostic Yield of External Loop Monitor VS. Wireless Tele ECG 109
FIG. 48 Cardiophone Real Time 24/7 Monitoring 110
FIG. 49 Canada Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 111
FIG. 50 Canada Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 112
FIG. 51 Rest of North America Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 113
FIG. 52 Rest of North America Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 113
FIG. 53 The annual cost of CVD in the USD in billion 115
FIG. 54 Europe Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 116
FIG. 55 Europe Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 116
FIG. 56 Europe Mobile Cardiac Telemetry Devices Market by Country, 2018- 2025 (USD Million) 117
FIG. 57 Proportional mortality in France by Disease Type (%) 118
FIG. 58 France Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 118
FIG. 59 France Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 119
FIG. 60 Ordinary Telephone Support & TLM Associated with Benefits in terms of Re-Hospitalization & Mortality 121
FIG. 61 Germany Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 122
FIG. 62 Germany Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 122
FIG. 63 THE RITH:M WAY 124
FIG. 64 Sweden Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 125
FIG. 65 Sweden Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 126
FIG. 66 Netherlands Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 128
FIG. 67 Netherlands Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 129
FIG. 68 Causes of Death in Italy by Gender, (%) 2014 130
FIG. 69 Italy Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 134
FIG. 70 Italy Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 134
FIG. 71 United Kingdom Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 136
FIG. 72 United Kingdom Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 136
FIG. 73 Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 137
FIG. 74 Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 138
FIG. 75 Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 139
FIG. 76 Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 140
FIG. 77 Asia Pacific Mobile Cardiac Telemetry Devices Market by Country, 2018-2025 (USD Million) 140
FIG. 78 Death rate of heart diseases among Japanese males from 2007 to 2016 (per 100,000 population) 141
FIG. 79 Japan Mobile Cardiac Telemetry Devices Market by Technology, 2018-2025 (USD Million) 142
FIG. 80 Japan Mobile Cardiac Telemetry Devices Market by End-User , 2018-2025 (USD Million) 143
FIG. 82 China Mobile Cardiac Telemetry Devices Market by Technology, 2018-2025 (USD Million) 145
FIG. 83 China Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 145
FIG. 85 India Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 147
FIG. 86 India Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 148
FIG. 87 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 149
FIG. 88 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 149
FIG. 89 Rest of World Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 151
FIG. 90 Rest of World Mobile Cardiac Telemetry Devices Market by End-User , 2018-2025 (USD Million) 151
FIG. 91 Rest of World Mobile Cardiac Telemetry Devices Market by Country, 2018-2025 (USD Million) 152
FIG. 92 South Africa Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 154
FIG. 93 South Africa Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 154
FIG. 94 Brazil Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 156
FIG. 95 Brazil Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 157
FIG. 96 Other Countries Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 157
FIG. 97 Other Countries Mobile Cardiac Telemetry Devices Market by End User, 2018-2025 (USD Million) 158
FIG. 98 Porter s Five forces analysis of the Global Mobile Cardiac Telemetry Devices Market 159
FIG. 99 Market Share of Key Players in Precision Agriculture, 2018 (%) 162
FIG. 100 Basic Concept of “Cs for Tomorrow 2018” Medium-Term Management Initiative, 2018 167
FIG. 101 Strengths of Asahi Kasei Corporation, 2018 167
FIG. 102 Asahi Kasei Corporation, SWOT Analysis 168
FIG. 103 Key Financials of Asahi Kasei Corporation 169
FIG. 104 Asahi Kasei Corporation, Revenue Split, 2018 (%) 170
FIG. 105 Key Features of BioTelemetry Inc. 173
FIG. 106 BioTelemetry Inc., SWOT Analysis 174
FIG. 107 Key Financials of BioTelemetry Inc. 175
FIG. 108 BioTelemetry Inc., Revenue Split, 2018 (%) 176
FIG. 109 Biotricity, Future Health Applications 179
FIG. 110 Bioflux- single-unit mobile cardiac telemetry (MCT) device 180
FIG. 111 Biolife-a personal heart monitor 180
FIG. 112 Biotricity, SWOT Analysis 182
FIG. 113 Key Financials of Biotricity 182
FIG. 114 Comarch, SWOT Analysis 188
FIG. 115 Key Financials of Comarch 189
FIG. 116 Comarch, Revenue Split, 2018 (%) 190
FIG. 117 Hill-Rom Holdings Inc., Key Facts 194
FIG. 118 Hill-Rom Holdings Inc., Commitment 196
FIG. 119 Hill-Rom Holdings Inc., SWOT Analysis 196
FIG. 120 Key Financials of Hill-Rom Holdings Inc 197
FIG. 121 Hill-Rom Holdings Inc, Revenue Split, 2018 (%) 198
FIG. 122 Traditional Practice Workflow 202
FIG. 123 Practice Workflow with MoMe Kardia 203
FIG. 124 Infobionic, SWOT Analysis 203
FIG. 125 Drivers Designed by Philips to Help Deliver Higher Levels of Customer Value and Quality, Boost Growth, Deliver Winning Solutions, And Improve Results 208
FIG. 126 Koninklijke Philips SWOT Analysis 208
FIG. 127 Key Financials of Koninklijke Philips N.V. 209
FIG. 128 Koninklijke Philips N.V, Revenue Split, 2018 210
FIG. 129 Key Facts of Medicalgorithmics 213
FIG. 130 Medicalgorithmics, SWOT Analysis 215
FIG. 131 Key Financials of Medicalgorithmics 216
FIG. 132 Medicalgorithmics, Revenue Split, 2018 (%) 217
FIG. 133 Medicomp, SWOT Analysis 221
FIG. 134 Cloud Based Preventice Care Platform Servers 224
FIG. 135 Preventice Solutions, Company Credentials 225
FIG. 136 Preventice Solutions, SWOT Analysis 225
List of Table
TABLE 1 Patients' Digital Health Adoption CVD Prevalence 34
TABLE 2 Patients' Digital Health Adoption for Measuring Fitness and Health Improvement (2015) 34
TABLE 3 Number and distribution of persons aged 60 years or over by region, in 2017 and 2050 36
TABLE 4 Top 10 Destinations for Medical Tourism 38
TABLE 5 Summary of Security Threats and Risks in PHDs 43
TABLE 6 Strengths and Efficacies of Different Transitional Care Models and Interventions 46
TABLE 7 Characteristics of ambulatory cardiac monitoring devices 49
TABLE 8 Estimated diagnostic yield of different AECG recording modalities 51
TABLE 9 Advantages and Major Limitations of AECG Techniques 52
TABLE 10 2014 CPT codes for AECG monitoring, Medicare fee schedule, and approved indications 54
TABLE 11 Reimbursement models in Europe 56
TABLE 12 Physician notification criteria for ambulatory cardiovascular telemetry 58
TABLE 13 Reimbursement of cardiologic activities from the NHS 59
TABLE 14 Policy Coverage Criteria 60
TABLE 15 Ambulatory Cardiac Rhythm Monitoring Devices 60
TABLE 16 Applicable Codes 62
TABLE 17 Codes for implantable cardiac monitoring devices (requires precertification) 63
TABLE 18 Codes that do not meet payment determination criteria: 63
TABLE 19 Select Recommendations for Ambulatory ECG and External Monitoring or Telemetry 64
TABLE 20 Provider awareness of telemetry use 68
TABLE 21 Top Product Launches under Mobile Cardiac Telemetry Devices 71
TABLE 22 Top Partnerships under Mobile Cardiac Telemetry Devices 73
TABLE 23 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 74
TABLE 24 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 76
TABLE 25 Indications for telemetry include, in consultation with the cardiology team, but not limited to 81
TABLE 26 Commercially Available Lead Based Mobile Telemetry Monitoring Systems 83
TABLE 27 A comprehensive overview of Existing Mobile Cardiac Monitoring devices 87
TABLE 28 Valuation of the B2C telemonitoring venture in the fifth year (in million US dollars)-Netherlands 127
TABLE 29 The Italian experience in TM programs 131
TABLE 30 mHealth benefits in 2017-Brazil 155
TABLE 31 Number of people with the four heart conditions in Brazil, 2015 156
TABLE 32 Asahi Kasei Corporation Key Facts 164
TABLE 33 The product segmentation of Asahi Kasei Corporation 165
TABLE 34 Asahi Kasei Corporation Growth Strategy 166
TABLE 35 Asahi Kasei Corporation Product Launches 170
TABLE 36 Asahi Kasei Corporation Partnerships 171
TABLE 37 Asahi Kasei Corporation Mergers and Acquisitions 171
TABLE 38 BioTelemetry Inc. Key Facts 172
TABLE 39 The product segmentation of BioTelemetry Inc. 173
TABLE 40 BioTelemetry Inc. Growth Strategy 173
TABLE 41 BioTelemetry Inc. Partnerships (Strategic Alliance) 176
TABLE 42 BioTelemetry Inc. Merger and Acquisitions 176
TABLE 43 Biotricity Key Facts 178
TABLE 44 The product segmentation of Biotricity 179
TABLE 45 Biotricity Growth Strategy 181
TABLE 46 Biotricity Product Launch 183
TABLE 47 Biotricity Business Expansion and Investments 184
TABLE 48 Comarch Key Facts 185
TABLE 49 Product segmentation of Comarch 186
TABLE 50 Comarch Growth Strategy 187
TABLE 51 Comarch Partnership 190
TABLE 52 Comarch Business Expansion & Investments 191
TABLE 53 Hill-Rom Holdings Inc, Inc Key Facts 192
TABLE 54 The product segmentation of Hill-Rom Holdings Inc 193
TABLE 55 Hill-Rom Holdings Inc Growth Strategy 194
TABLE 56 Hill-Rom Holdings Inc Product Launches 198
TABLE 57 Hill-Rom Holdings Inc Partnership 199
TABLE 58 Hill-Rom Holdings Inc Expansions and Investments 199
TABLE 59 Hill-Rom Holdings Inc Mergers and Acquisitions 199
TABLE 60 Hill-Rom Holdings Inc Product Launches 200
TABLE 61 Infobionic Key Facts 201
TABLE 62 The product segmentation of InfoBionic 201
TABLE 63 Infobionic Growth Strategy 202
TABLE 64 Infobionic Product Launch 204
TABLE 65 Infobionic Business Expansion and Investment 204
TABLE 66 Koninklijke Philips N.V. Key Facts 205
TABLE 67 The product segmentation of Koninklijke Philips N.V. 206
TABLE 68 Koninklijke Philips N.V. Growth Strategy 207
TABLE 69 Koninklijke Philips N.V. Product Launches 210
TABLE 70 Koninklijke Philips N.V. Partnership 211
TABLE 71 Koninklijke Philips N.V. Merger and Acquisition 211
TABLE 72 Medicalgorithmics Key Facts 212
TABLE 73 The product segmentation of Medicalgorithmics 213
TABLE 74 Medicalgorithmics Growth Strategy 214
TABLE 75 Medicalgorithmics Product Launch 217
TABLE 76 Medicalgorithmics Partnerships 218
TABLE 77 Medicalgorithmics Business Expansions and Investments 218
TABLE 78 Medicalgorithmics Merger & Acquisitions 218
TABLE 79 Medicomp Key Facts 219
TABLE 80 The product segmentation of Medicomp 219
TABLE 81 Medicomp Growth Strategy 220
TABLE 82 Medicomp Corp Product Launches 221
TABLE 83 Preventice Solutions Key Facts 222
TABLE 84 The product segmentation of Preventice Solutions 223
TABLE 85 Preventice Solutions Growth Strategy 224
TABLE 86 Preventice Solutions Product Launches 226
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.